Ticker Details
Forte Biosciences, Inc.
IPO Date:	April 10, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$442.14M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.70 | 4.20%
Avg Daily Range (30 D):	$1.25 | 4.51%
Avg Daily Range (90 D):	$1.21 | 4.21%

Institutional Daily Volume
Avg Daily Volume:	.14M
Avg Daily Volume (30 D):	.22M
Avg Daily Volume (90 D):	.23M

Trade Size
Avg Trade Size (Sh.):	144
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	141
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$1.86M
Avg Institutional Trade (90 D):	$1.99M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.17M
Avg Closing Trade (30 D):	$2M
Avg Closing Trade (90 D):	$2.69M
Avg Closing Volume:	36.33K

News

Aug 14, 2025 @ 5:00 PM Vitiligo Clinical Trial Pipeline Accelerates as 18... Source: Delveinsight

Jul 4, 2025 @ 10:00 AM Forte and Sequence Partner to Power Web3 Monetizat... Source: Bela Pandya (Forte Ceo)

Mar 25, 2024 @ 4:00 PM What Makes Forte Biosciences (FBRX) a New Buy Stoc... Source: Zacks Equity Research

Dec 13, 2023 @ 1:29 PM Research Frontiers And 3 Other Stocks Under $1 Ins... Source: Avi Kapoor

Dec 11, 2023 @ 1:34 PM RiskOn International And 3 Other Stocks Under $2 I... Source: Avi Kapoor

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.24	$-1.45	$-4.71
Diluted EPS	$-1.24	$-1.45	$-4.71
Revenue	$M	$2.72M	$2.72M
Gross Profit
Net Income / Loss	$-22.14M	$-24.79M	$-69.38M
Operating Income / Loss	$-22.44M	$-24.57M	$-70.66M
Cost of Revenue
Net Cash Flow	$M	$-16.46M	$54.71M
PE Ratio

Splits
Aug 28, 2024	1:25